Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Seidman

Showing results (291-300 of 386) with videos related to

Pageof 39
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1995
Phase II trial of paclitaxel by 3-hour infusion as initial and salvage chemotherapy for metastatic breast cancerA D Seidman, A Tiersten, C Hudis, et al.
Human Pathology|May 1, 1991
DNA analysis of cardiac myxomas: flow cytometry and image analysisJ D Seidman, J J Berman, C L Hitchcock, et al.
NPJ Breast Cancer|October 22, 2023
Incidence of HER2-expressing brain metastases in patients with HER2-null breast cancer: a matched case analysisNelson S Moss, Jolene M Singh, Anne S Reiner, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|February 6, 2013
Resveratrol decreases noise-induced cyclooxygenase-2 expression in the rat cochleaMichael D Seidman, Wenxue Tang, Venkatesh Uma Bai, et al.
Neuro-Oncology|January 29, 2014
Phase II trial of patupilone in patients with brain metastases from breast cancerDavid M Peereboom, Conleth Murphy, Manmeet S Ahluwalia, et al.
Seminars in Oncology|December 1, 1995
Sequential adjuvant therapy with doxorubicin/paclitaxel/cyclophosphamide for resectable breast cancer involving four or more axillary nodesC A Hudis, A D Seidman, J Baselga, et al.
Seminars in Oncology|November 28, 1997
Dose-dense therapy with paclitaxel via weekly 1-hour infusion: preliminary experience in the treatment of metastatic breast cancerA D Seidman, C A Hudis, J McCaffrey, et al.
Journal of the National Cancer Institute|September 6, 1995
Quality of life in phase II trials: a study of methodology and predictive value in patients with advanced breast cancer treated with paclitaxel plus granulocyte colony-stimulating factorA D Seidman, R Portenoy, T J Yao, et al.
Breast Cancer Research and Treatment|June 10, 2021
A phase I trial of sorafenib with whole brain radiotherapy (WBRT) in breast cancer patients with brain metastases and a correlative study of FLT-PET brain imagingAki Morikawa, Milan Grkovski, Sujata Patil, et al.
JAMA Network Open|January 31, 2025
Survival Among Patients With ERBB2-Positive Metastatic Breast Cancer and Central Nervous System DiseaseEmanuela Ferraro, Anne S Reiner, Rabih Bou Nassif, et al.
Pageof 39

Showing results (291-300 of 386) with videos related to

Sort By:
Pageof 39
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1995
Phase II trial of paclitaxel by 3-hour infusion as initial and salvage chemotherapy for metastatic breast cancerA D Seidman, A Tiersten, C Hudis, et al.
Human Pathology|May 1, 1991
DNA analysis of cardiac myxomas: flow cytometry and image analysisJ D Seidman, J J Berman, C L Hitchcock, et al.
NPJ Breast Cancer|October 22, 2023
Incidence of HER2-expressing brain metastases in patients with HER2-null breast cancer: a matched case analysisNelson S Moss, Jolene M Singh, Anne S Reiner, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|February 6, 2013
Resveratrol decreases noise-induced cyclooxygenase-2 expression in the rat cochleaMichael D Seidman, Wenxue Tang, Venkatesh Uma Bai, et al.
Neuro-Oncology|January 29, 2014
Phase II trial of patupilone in patients with brain metastases from breast cancerDavid M Peereboom, Conleth Murphy, Manmeet S Ahluwalia, et al.
Seminars in Oncology|December 1, 1995
Sequential adjuvant therapy with doxorubicin/paclitaxel/cyclophosphamide for resectable breast cancer involving four or more axillary nodesC A Hudis, A D Seidman, J Baselga, et al.
Seminars in Oncology|November 28, 1997
Dose-dense therapy with paclitaxel via weekly 1-hour infusion: preliminary experience in the treatment of metastatic breast cancerA D Seidman, C A Hudis, J McCaffrey, et al.
Journal of the National Cancer Institute|September 6, 1995
Quality of life in phase II trials: a study of methodology and predictive value in patients with advanced breast cancer treated with paclitaxel plus granulocyte colony-stimulating factorA D Seidman, R Portenoy, T J Yao, et al.
Breast Cancer Research and Treatment|June 10, 2021
A phase I trial of sorafenib with whole brain radiotherapy (WBRT) in breast cancer patients with brain metastases and a correlative study of FLT-PET brain imagingAki Morikawa, Milan Grkovski, Sujata Patil, et al.
JAMA Network Open|January 31, 2025
Survival Among Patients With ERBB2-Positive Metastatic Breast Cancer and Central Nervous System DiseaseEmanuela Ferraro, Anne S Reiner, Rabih Bou Nassif, et al.
Pageof 39